Physician profile
Pratap Challa
NPI 1982794137
$3,320.36
in general payments reported to CMS, 2019-2025
8 companies · $277 in 2025
The $277 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,078 · 2020: $1,550 · 2021: $223 · 2022: $78.16 · 2024: $115 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $391.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $2,815.95 | 2019-2021 | |
| Nova Eye, INC. | $151.11 | 2025 | |
| Abbvie INC. | $125.40 | 2025 | |
| Bausch & Lomb Americas INC. | $115.15 | 2024 | Stellaris |
| Alcon Vision LLC | $45.86 | 2022 | |
| Carl Zeiss Meditec Cataract Technology INC. | $44.28 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $11.53 | 2019 | |
| Glaukos Corporation | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pratap Challa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.